Zuranolone Will Be a New Rx for Postpartum Depression
April 2026
Oral zuranolone (Zurzuvae) will be the first med approved for treating postpartum depression.
Zuranolone starts to improve depression symptoms within days.
This is quicker than SSRIs (sertraline, etc) for postpartum depression...which take at least 1 to 2 weeks to start working.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote